Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Taxes (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Change in Taxes for 7 consecutive years, with -$22.6 million as the latest value for Q3 2025.

  • Quarterly Change in Taxes changed N/A to -$22.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$22.7 million through Sep 2025, changed N/A year-over-year, with the annual reading at $258000.0 for FY2020, 93.03% down from the prior year.
  • Change in Taxes for Q3 2025 was -$22.6 million at Theravance Biopharma, down from $295000.0 in the prior quarter.
  • The five-year high for Change in Taxes was -$22.6 million in Q3 2025, with the low at -$22.6 million in Q3 2025.